🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 2 study aims to improve preparedness for future Ebola outbreaks ...
Status
Completed
Location
Hôpital Général de Référence de Boende
Start Date
2019-12-18
Trial ID
NCT04186000
Treatments Being Tested
The purpose of this study is to test the safety and immunogenicity of MVA-B...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02376400
Treatments Being Tested
The purpose of this study is to assess the safety and reactogenicity of a h...
Status
Completed
Location
Centre National de Formation et de Recherche en Sante Rurale de Maferinyah
Start Date
2019-08-19
Trial ID
NCT03929757
Treatments Being Tested
The VAC52150EBL3005 (EBOVAC-Salone Extension) is a cohort study evaluating ...
Status
Completed
Location
EBOVAC Rokupr clinic
Start Date
2019-07-22
Trial ID
NCT03820739
Treatments Being Tested
An open-label, single arm phase II study of the candidate Ebola Vaccine Ad2...
Status
Completed
Location
MRC/UVRI & LSHTM Uganda Research Unit
Start Date
2019-08-01
Trial ID
NCT04028349
Treatments Being Tested
The aim of this study is to investigate the persistence of the vaccine indu...
Status
Completed
Location
MRC - University of Glasgow Centre for Virus Research
Start Date
2017-05-17
Trial ID
NCT03140774
Treatments Being Tested
The purpose of this study is: a) to assess adverse maternal/fetal outcomes ...
Status
Completed
Location
Gihundwe District Hospital
Start Date
2020-10-05
Trial ID
NCT04556526
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Multiple Locations
Start Date
2015-06-15
Trial ID
NCT02416453
Treatments Being Tested
The purpose of this study is to test the safety and immunogenicity of MVA-B...
Status
Completed
Location
Multiple Locations
Start Date
2016-08
Trial ID
NCT02860650
Treatments Being Tested
This is an open-label study evaluating the safety and immunogenicity of a b...
Status
Completed
Location
EBOVAC Kambia 1 clinic
Start Date
2021-07-08
Trial ID
NCT04711356
Treatments Being Tested